The Safety of Edaravone for patients with Amyotrophic Lateral Sclerosis: Single centered open label trial
Phase 1
- Conditions
- amyotrophic lateral sclerosis
- Registration Number
- JPRN-UMIN000016352
- Lead Sponsor
- Ehime University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Severe kidney failure Past history with hyper-reaction against Edaravone Physician's opinion against participation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adverse effects leading discontinuation of the medication
- Secondary Outcome Measures
Name Time Method 1. Respiratory volume 2. ALSFRS: Amyotrophic Lateral Screlosis Functional Rating Scale